Combination of Sanguisorbigenin and Conventional Antibiotic Therapy for Methicillin-Resistant <i>Staphylococcus aureus</i>: Inhibition of Biofilm Formation and Alteration of Cell Membrane Permeability.

Wang, Shu; Liu, Xiang-Qian; Kang, Ok-Hwa; Kwon, Dong-Yeul

Combination of Sanguisorbigenin and Conventional Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus: Inhibition of Biofilm Formation and Alteration of Cell Membrane Permeability.

Wang, Shu; Liu, Xiang-Qian; Kang, Ok-Hwa; Kwon, Dong-Yeul.

Afiliação

Wang S; Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University, Iksan 54538, Korea.
Liu XQ; School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Kang OH; Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University, Iksan 54538, Korea.
Kwon DY; Department of Oriental Pharmacy, College of Pharmacy and Wonkwang Oriental Medicines Research Institute, Wonkwang University, Iksan 54538, Korea.

Int J Mol Sci ; 23(8)2022 Apr 11.

Article em En | MEDLINE | ID: mdl-35457049

Assuntos

Staphylococcus aureus Resistente à Meticilina; Antibacterianos/farmacologia; Biofilmes; Permeabilidade da Membrana Celular; Testes de Sensibilidade Microbiana

Palavras-chave

MRSA; Sanguisorba officinalis L.; biofilm; membrane; synergy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Plantas_medicinales Assunto principal: Staphylococcus aureus Resistente à Meticilina Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google